Home60Q • FRA
add
Captor Therapeutics SA
Previous close
€7.52
Day range
€7.44 - €7.50
Year range
€7.30 - €18.00
Market cap
175.31M PLN
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.61M | -42.15% |
Operating expense | 12.45M | -2.02% |
Net income | -10.72M | -13.55% |
Net profit margin | -411.32 | -96.30% |
Earnings per share | — | — |
EBITDA | -9.49M | -10.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.42M | -5.35% |
Total assets | 74.09M | -11.24% |
Total liabilities | 19.94M | -16.02% |
Total equity | 54.14M | — |
Shares outstanding | 5.53M | — |
Price to book | 0.76 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.72M | -13.55% |
Cash from operations | 23.06M | 324.92% |
Cash from investing | -44.60M | -10,821.63% |
Cash from financing | -1.09M | -12.69% |
Net change in cash | -22.63M | -109.45% |
Free cash flow | — | — |
About
Founded
2015
Website
Employees
91
